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Abstract: Introduction: Chronic subdural hematoma in clipped patients of unruptured 
intracranial aneurysms might lead to sudden neurological deterioration and may need 
emergency evacuation. We studied the effects of various factors in its etiology. 
Materials and methods: A retrospective study of 91operated clipped patients of 
unruptured aneurysms in the year 2014-2015 was taken. Various predisposing factors 
were studied. Results: Goreisan use was not associated with any reduction in post 
operative CSDH formation. Arachnoidoplasty and reduced post operative dead space 
contributed in a reduced formation of CSDH. Conclusion: Older male patients with 
aneurysms who had been treated with anticoagulant drugs should be considered 
candidates for additive ARP to prevent the development of postoperative CSDH. 
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Introduction 
Chronic subdural hematoma (CSDH) is 
one of the most common neurosurgical 
complications and one of the most under 
reported complication following clipping of 
unruptured aneurysms. It may lead to sudden 
neurological deterioration and might need 
surgical evacuation. Mori and Maeda 
reported that post operative complications of 
CSDH occurred in 5.4% of patients (1). 
Most of the patients of CSDH are treated 
by surgical evacuation, although there are 
some who have been treated by 
corticosteroids (2), angiotensin converting 
enzyme inhibitors (3), hypertonic glucose (4) 
and mannitol (5). Recently, especially in 
Japan, the use of traditional herbal medicine 
in the prevention of CSDH in post operative 
cases has come into prevalence (6).  
Goreisan is believed to have two 
important actions-One is the diuretic action 
and the other is hydrostatic modulating 
action in which the movement of water 
molecules is adjusted (7). 
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We report our institutional experience 
with Goreisan in operated unruptured 
aneurysm cases. 
Materials and methods 
We conducted a retrospective study in the 
year 2014-2015. All patients of unruptured 
intracranial aneurysms of any age and sex, 
with follow up for one year were included in 
the study. A total of 91 patients were thence 
enrolled for the present study. Different 
factors were evaluated- age and sex of the 
patient, anti coagulant use, post operative 
pneumocephalus, arachnoidoplasty, and 
Goreisan use. 91 clipped patients of 
unruptured aneurysms who later developed 
CSDH were included in the study. The 
patients were divided into two groups.  In the 
first group, 21 cases were symptomatic CSDH 
causing either mass effect or deterioration in 
consciousness and required surgical 
evacuation. The second group had 70 cases 
which were asymptomatic or small CSDH 
and managed conservatively. Single burr hole 
evacuation method was deployed for 
evacuation of CSDH. Routine follow up of 
these patients over a period of 1 year was 
performed. 
Statistical analysis 
For age comparison, student t-test 
(unpaired) was used. Rest data was 
qualitative, analysed by Chi square test. 
Results 
TABLE I 
Showing characteristics in groups operated for CSDH and those not operated following clipping 
 GROUP 1: 21/91 (23%) GROUP 2: 70/91 (77%) 
MEAN AGE 69.5 years (p<0.015) 64.44 years 
MALE:FEMALE 11:10 8:62 
GOREISAN USE 17/21 48/70 
ANTICOAGULANT  3/21 (p =0.044) 2/70 
DEAD SPACE 19/21(90.5%) 27/70 
ARACHNOIDOPLASTY 4/21 31/70 
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Figure 1 - case illustration of 76 years female with A: 
left MCA aneurysm, B: post operative Day 1 CT scan 
showing  bifrontal pneumocephalus, C: 2 months 
following surgery patient had left CSDH causing 
mass effect, D: following evacuation of the hematoma 
Discussion 
Although the pathogenesis of CSDH is not 
completely understood, various key points 
need to be highlighted. Subdural effusion is 
believed to be the result of arachnoid tearing 
by neurosurgical intervention, which causes 
fluid with or without blood to invade the 
subdural space and facilitate the formation of 
outer membrane (8), which then forms 
internal capillaries or sinusoids. These 
fenestrated blood vessels allow plasma fluid 
leakage and the resultant enlargement of the 
subdural space. Repeated bleeding occurs 
from degenerating endothelium of capillaries 
which is accompanied by local 
hyperfibrinolysis. CSDH tends to occur in 
patients in elderly patients of unruptured 
aneurysms, because brain atrophy tends to 
cause enlargement of the subarachnoid space 
and stretching of the bridging veinswhich 
facilitate the tearing of the arachnoid 
membrane and leakage of bloody 
cerebrospinal fluid into subdural space. 
Our series reported a higher incidence of 
CSDH, as all the patients operated were 
unruptured aneurysms which had a lax brain 
compared to other series which had a much 
lower incidence of CSDH, due to their 
clipping in ruptured aneurysms. Secondly, 
with the suctioning of CSF from cisterns, the 
laxed brain in unruptured aneurysms became 
all the more laxed.  
We noted a reduced incidence of post 
operative CSDH in male patients, which may 
be countered by absence of oestrogen, which  
may cause the blood vessels in the inner dural 
layer to become more ectatic because of 
estrogen priming of these vessels and thus 
more likely to bleed (9). 
Some studies have reported an important 
role of Aquaporin 4 (AQP4) in CSDH. Utsuki 
et al reported that AQP4 is expressed in the 
outer membrane of CSDH (10). Aquaporins 
are a family of transmembrane channels that 
allow rapid movement of water and in some 
cases small molecules across the plasma 
membrane, hence playing a critical role in 
brain edema pathogenesis (11,12). Goreisan 
inhibits AQP4 (13), which is expressed on the 
outer membrane of CSDH. Asano et al also 
described the AQP blocking action of 
Goreisan (14). However, our study did not 
find any particular benefit with the usage of 
goreisan.  
Torn arachnoid causes a direct contact 
between subdural space and the cortex, which 
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leads to continued oozing from the 
capillaries, hence leading to increase 
formation of CSDH. We found that with the 
use of arachnoidoplasty, the incidence of 
CSDH was overtly reduced in our patients.  
We recommend that older male patients 
with aneurysms who had been treated with 
anticoagulant drugs should be considered 
candidates for additive ARP to prevent the 
development of postoperative CSDH. 
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